Skip to main content

Another Asbestos-In-Talc Trial Begins in California Court

Another Asbestos-In-Talc Trial Begins in California Court

Another Asbestos-In-Talc Trial Begins in California Court

Introduction

A 94-year old mesothelioma victim succumbed to death due to the exposure to asbestos used in Johnson & Johnson Talcum powder. On May 29, during the first day of the trial for this case, in  California, her attorney alleged that the talcum manufacturer is liable for her death. However, the company countered the statement stating smoking asbestos-laden cigarettes led to her mesothelioma.

Last month, a banker with the same diagnosis was awarded $117 million in punitive and compensatory damages by a New Jersey jury. Over 6,600 lawsuits are filed nationwide by women who claim they developed ovarian cancer after using J&J's Talcum Powder for feminine hygiene purposes.

Similar allegations are filed against J&J in state courts in California, New Jersey, and Delaware and consolidated for pre-trial proceedings in the U.S. District Court for the District of New Jersey MDL No. 2738 (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!